Investor Overview At Gilead we are inspired by the opportunity to address unmet medical needs for patients living with life-threatening diseases around the world. Stock Quote Stock Quote Volume: Apr 25, 2019 7:40 PM EDT Latest News April 25, 2019 Gilead Announces Topline Data From Phase 3 STELLAR-3 Study of Selonsertib in Bridging Fibrosis (F3) Due to Nonalcoholic Steatohepatitis (NASH) April 24, 2019 Kite Announces Plans for New State-of-the-Art Facility to Expand Cell Therapy Production Capabilities April 18, 2019 Gilead Sciences to Release First Quarter 2019 Financial Results on Thursday, May 2, 2019 View All Events May 8, 2019 at 10:00 AM PDT Gilead Sciences 2019 Stockholders Meeting May 2, 2019 at 4:30 PM EDT First Quarter 2019 Gilead Sciences Earnings Conference Call Mar 12, 2019 at 10:45 AM EDT Gilead Sciences at the Barclays Global Healthcare Conference View All
